ANJALI SHAH's Insider Trades & SAST Disclosures
ANJALI SHAH's most recent trade in Remus Pharmaceuticals Ltd. was a Buy of 200 Equity Shares done at an average price of Rs. 4700 . Disclosure was reported to the exchange on Aug. 18, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for ANJALI SHAH in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | ANJALI SHAH | Key Managerial Personnel | Buy | 18 Aug 2023 | 200 | 200 | - | 4700 | 940,000 | 16 Aug 2023 16 Aug 2023 |
Insider Trading (-) | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.